Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders)....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Agha, Mounzer E, Blake, Maggie, Chilleo, Charles, Wells, Alan, Haidar, Ghady
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8320282/
https://ncbi.nlm.nih.gov/pubmed/34337100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab353
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky